Litigation and Trial
Client Counselling, Licensing and Technology Transfer
Law clerk to the Honourable H Dale Cook US District Court Judge, ND, Oklahoma – 1997–1998
Patent attorney - Greenblum and Bernstein, PLC – 1999–present.
Secretary, U.S. Section (2017–present), US Council member – International Association for the Protection of Intellectual Property (FICPI) (2013–2017)
Member – FICPI CET8 – IP Licensing and Monetization international working group
Certified Patent Valuation Analyst Faculty Member (2011-present)
Licensing Executive Society (2010-present, Sector Liaison – Publications)
Licensing Executive Society (2010-present, Sector Liaison – Communications)
Generic Pharmaceutical Association (GPhA) (2004–present, Membership Committee)
University of Arkansas Vice Chancellor’s Advisory Council (2007–present, board member and Chairman 2008–09)
Speaks as well as participates and moderates panel discussions at various professional meetings and webinars, including FICPI and LES meetings as well as industry organisations such as ChemInnovations and GPhA.
Argued cases before the Court of Appeals for the Federal Circuit and various US District Courts nationwide, including all hearings as well as bench and jury trials.
Developed patent monetisation strategies, and participated in the negotiation and sale of patent portfolios.
Completed a mini-pupilage under Roger Wyand, QC of Grey’s Inn, London, England, practising intellectual property law before the Royal Courts of Justice.
Developed and oversaw environmental compliance programmes for one of largest transportation companies in the nation, including nationwide underground storage tank and fueling facility upgrades and compliance programme.
American Bar Association
American Intellectual Property Law Association
Generic Pharmaceutical Association
International Federation of Intellectual Property Attorneys
International Association for the Protection of Intellectual Property
Licensing Executive Society
Pejic PB., ‘Will Credible Utility Join Written Description and Enablement as the Newest Patent Infringement Defense?’. Journal of Generic Medicines, vol. 14, 3, pp. 135-140, first published December 1, 2017.
Pejic PB., ‘On Litigating Hatch-Waxman Patent Infringement Cases in the Eastern District of Virginia’ Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector April 2014 11(1-2) 74-77.
Bernstein, B., Fink, M., Pejic, P.B. 2011-2017 editions ‘Licensing U. Jurisdiction’. Getting The Deal Through - in print and online, Law Business Research Ltd.
Pejic, PB, ‘Recent Federal Circuit rulings strengthen obviousness-type double patenting defense to assertions of patent infringement in pharmaceutical litigations’. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, April 2011 8: 111-116.
Greenblum, N., Fink, M., Roylance, S., Pejic, P.B., Myers-Payne, S.C., Braier, P. ‘Generic Drugs in a Changing Intellectual Property Landscape’. The Pharmaceutical Regulatory Process, Second Edition, pp. 143-180, Ira R. Berry and Robert P. Martin, eds. Informa Health Care (2008).
University of Arkansas, BS in Chemical Engineering (1993)
University of Tulsa College of Law, JD (1997)
Georgetown University Law Center, LLM in International and Comparative Law, with focus on Intellectual Property and International Trade (1999).
2007, District of Columbia